Sol-Gel Technologies (SLGL) Non-cash Items (2016 - 2020)
Sol-Gel Technologies (SLGL) reported Non-cash Items of $2.1 million for Q4 2020, down 5.85% year-over-year from $2.3 million in Q1 2020, and down 5.85% on a QoQ basis from $2.3 million in Q4 2019.
Sol-Gel Technologies (SLGL) has 5 years of Non-cash Items data on file, last reported at $2.1 million in Q4 2020.
- Quarterly Non-cash Items fell 5.85% year-over-year to $2.1 million in Q4 2020, while the trailing twelve-month figure through Dec 2020 was $2.1 million (down 5.85% YoY) and the FY2020 annual result came in at $2.1 million, down 5.85% from the prior year.
- Non-cash Items retreated to $2.1 million in Q4 2020 per SLGL's latest filing, from $2.3 million in the prior quarter.
- Across five years, Non-cash Items topped out at $2.3 million in Q4 2019 and bottomed at $7614.0 in Q4 2017.
- The 5-year median for Non-cash Items is $192338.0 (2016), against an average of $931549.0.
- The widest annual swing landed in 2017, when Non-cash Items sank 96.04%; it then soared 4974.45% in 2019.
- Tracing SLGL's Non-cash Items over 5 years: stood at $192338.0 in 2016, then slumped by 96.04% to $7614.0 in 2017, then jumped by 488.3% to $44793.0 in 2018, then soared by 4974.45% to $2.3 million in 2019, then dropped by 5.85% to $2.1 million in 2020.
- Per Business Quant, the three latest SLGL Non-cash Items figures stand at $2.1 million (Q4 2020), $2.3 million (Q4 2019), and $44793.0 (Q4 2018).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Sol-Gel Technologies | 205.76 Mn | 194.73 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 2.14 Mn |
| Dec 31, 2020 | 2.14 Mn |
| Dec 31, 2019 | 2.27 Mn |
| Dec 31, 2019 | 2.27 Mn |
| Dec 31, 2018 | 44,793.00 |
| Dec 31, 2018 | 44,793.00 |
| Dec 31, 2017 | 7,614.00 |
| Dec 31, 2017 | 7,614.00 |
| Dec 31, 2016 | 192,338.00 |
| Dec 31, 2016 | 192,338.00 |